Discussing Rheumatology: Safety of filgotinib, and tofacitinib in pJIA
Prof Iain McInnes reviews two papers this month, and discusses exposure-adjusted incidence rates of TEAEs and AESIs with filgotinib, as well as the efficacy and safety of tofacitinib in pJIA. Keep up ...
23 Joulu 20218min
Author Interview: Professor Kevin Winthrop (December 2021)
Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Pro...
23 Joulu 202122min
Author Interview: Professor Kevin Winthrop (November 2021)
Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Pro...
22 Joulu 202120min
Insights at ACR 2021: Basic Science / Beyond RA
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
14 Joulu 202140min
Insights at ACR 2021: PROs and JAK Treatment
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
13 Joulu 202148min
Insights at ACR 2021: Clinical Outcomes in RA
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
12 Joulu 202147min
Insights at ACR 2021: JAKs in Spondyloarthritis
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
11 Joulu 202130min
Insights at ACR 2021: COVID-19 Vaccination and Rituximab
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
10 Joulu 202131min
